Immediate Impact
10 by Nobel laureates 9 from Science/Nature 77 standout
Citing Papers
Past, present, and future of CRISPR genome editing technologies
2024 Standout
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Works of Jonathan K. Watts being referenced
Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides
2022
The chemical evolution of oligonucleotide therapies of clinical utility
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jonathan K. Watts | 3360 | 180 | 109 | 580 | 308 | 79 | 4.1k | |
| M. Teresa Pisabarro | 3611 | 357 | 59 | 482 | 416 | 99 | 4.9k | |
| Makoto Adachi | 3081 | 294 | 205 | 324 | 228 | 101 | 4.5k | |
| John J. Correia | 2570 | 161 | 63 | 349 | 324 | 98 | 3.8k | |
| Robert A. Tobey | 4402 | 176 | 77 | 754 | 549 | 118 | 6.2k | |
| Jeffrey M. Besterman | 4204 | 604 | 262 | 288 | 285 | 98 | 5.5k | |
| Sebastian Müller | 2680 | 231 | 59 | 591 | 132 | 67 | 3.9k | |
| Thazha P. Prakash | 5296 | 335 | 18 | 740 | 327 | 113 | 5.9k | |
| Joseph A. Walder | 2985 | 106 | 39 | 227 | 462 | 56 | 4.2k | |
| Roland S. Annan | 4398 | 166 | 167 | 299 | 231 | 75 | 5.9k | |
| Sandra B. Gabelli | 3552 | 311 | 147 | 243 | 251 | 100 | 5.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...